Discover the Function and Significance of CD155 in Immune Regulation

Discover the cutting-edge medical innovation developed by Alpha Lifetech Incorporation: CD155, a revolutionary biotherapy product aimed at improving cancer treatment outcomes. CD155 is a monoclonal antibody that targets and blocks the CD155 protein, which is overexpressed in various types of cancer cells. By inhibiting the interaction between CD155 and its receptors, CD155 works to enhance the body's immune response against cancer, ultimately leading to more effective tumor regression, With its innovative mechanism of action, CD155 presents a promising solution for patients with advanced or metastatic forms of cancer, who may have limited treatment options available. Alpha Lifetech Incorporation is dedicated to advancing cancer care, and CD155 is a testament to our commitment to developing next-generation therapies that positively impact patient outcomes